Macrophages play a critical role in pancreatitis progression and pancreas regeneration. Heparin-binding epidermal growth factor receptor-like growth factor derived from myeloid cells is not involved in the initiation of pancreatitis, but contributes to pancreas recovery after pancreatitis by promoting DNA damage repair.
BACKGROUND & AIMS:
Pancreatitis is a major cause of morbidity and mortality and is a risk factor for pancreatic tumorigenesis. Upon tissue damage, an inflammatory response, made up largely of macrophages, provides multiple growth factors that promote repair. Here, we examine the molecular pathways initiated by macrophages to promote pancreas recovery from pancreatitis.
METHODS:
To induce organ damage, mice were subjected to cerulein-induced experimental pancreatitis and analyzed at various times of recovery. CD11b-DTR mice were used to deplete myeloid cells. Hbegf f/f ;LysM-Cre mice were used to ablate myeloid cell-derived heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF). To ablate EGFR specifically during recovery, pancreatitis was induced in Egfr f/f ;Ptf1a FlpO/þ ;FSFRosa26 CAG-CreERT2 mice followed by tamoxifen treatment.
RESULTS:
Macrophages infiltrating the pancreas in experimental pancreatitis make high levels of HB-EGF. Both depletion of myeloid cells and ablation of myeloid cell HB-EGF delayed recovery from experimental pancreatitis, resulting from a decrease in cell proliferation and an increase in apoptosis. Mechanistically, ablation of myeloid cell HB-EGF impaired epithelial cell DNA repair, ultimately leading to cell death. Soluble HB-EGF induced EGFR nuclear translocation and methylation of histone H4, facilitating resolution of DNA damage in pancreatic acinar cells in vitro. Consistent with its role as the primary receptor of HB-EGF, in vivo ablation of EGFR from pancreatic epithelium during recovery from pancreatitis resulted in accumulation of DNA damage. P ancreatitis is a type of tissue injury commonly associated with heavy alcohol consumption, smoking, and ductal blockage by gallstones. Although acute pancreatitis can be mild and self-resolving, at its most severe it can be a necrotizing disease leading to endocrine and/or exocrine impairment and even multiple organ dysfunction. Repeated bouts of acute pancreatitis also can become fibrotic chronic pancreatitis, a risk factor for pancreatic cancer. 1 Pancreatitis is the most frequent cause of hospitalization in gastrointestinal diseases. 2, 3 During pancreatitis, acinar cell dropout results from apoptosis, necrosis, and necroptosis, 4 while some acinar cells undergo transdifferentiation to ductal structures in a process known as acinar-to-ductal metaplasia (ADM). [5] [6] [7] ADM can act as a precursor of neoplasia upon oncogenic mutation of Kras, 8, 9 which can progress to pancreatic cancer. In ceruleininduced experimental pancreatitis in mice, ADM is a cell survival mechanism in the face of abundant tissue damage and cell death. Upon injury resolution, metaplastic epithelia can redifferentiate back to acinar cells, restoring homeostasis. 10, 11 One of the hallmarks of pancreatitis is an influx of innate immune cells, including a large number of macrophages. 12, 13 Numerous experimental and clinical studies have indicated that proinflammatory mediators (eg, tumor necrosis factor [TNF-a], interleukin [IL]6, IL8, and so forth) released from acinar cells induce macrophage infiltration, which supports the progression of pancreatitis. [14] [15] [16] [17] [18] Macrophages contribute to the pancreatitis phenotype by inducing ADM and fibrogenesis. 18, 19 Conversely, macrophages are important for tissue regeneration under conditions in which most of the pancreatic epithelial cells are ablated, 20 suggesting that they produce factors that promote cell proliferation and differentiation after severe injury.
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) initially was identified in conditioned medium of cultured human macrophages, 21 and is highly expressed in macrophages associated with human pancreatic cancer and chronic pancreatitis. 22 HB-EGF is synthesized as a transmembrane protein and shed by a disintegrin and metalloproteinases (ADAMs) to become a soluble growth factor, capable of binding to the receptors EGF receptor (EGFR) and Receptor tyrosine-protein kinase erbB-4 (ERBB4). 23 The transmembrane precursor of HB-EGF is also biologically active and can signal in a juxtacrine fashion to adjacent cells. 24 HB-EGF binding to EGFR/ERBB4 activates downstream signaling cascades that are associated with cell survival, proliferation, and migration. Indeed, ectopic HB-EGF promotes keratinocyte migration in skin wound healing. 25, 26 Together with its function in other types of wound repair, we hypothesized that macrophage-derived HB-EGF plays an important role in pancreas recovery after pancreatitis-associated injury.
In the current study, we genetically ablated HB-EGF exclusively from myeloid cells to definitively determine its contribution to pancreas wound healing. In a model of severe acute experimental pancreatitis, ablation of myeloid HB-EGF had no significant effect on ADM induction or inflammatory cell infiltration, but drastically inhibited tissue repair, phenocopying the effects of widespread ablation of myeloid cells during this recovery phase. HB-EGF ablation from myeloid cells decreased epithelial cell proliferation, enhanced cell death, and slowed DNA repair, effects that manifested after cessation of cerulein-induced injury. We found that HB-EGF enhanced DNA repair through induction of EGFR nuclear localization and histone H4 methylation. Our findings clearly show that myeloid-derived HB-EGF is uniquely required for epithelial cell DNA repair and tissue restoration after pancreatic injury in vivo.
Results

Myeloid Cells Are Required for Tissue Recovery After Experimental Pancreatitis
Macrophages are required for pancreatic cell regeneration after mass ablation of pancreatic epithelia, 20 leading us to investigate whether myeloid cells similarly contribute to organ recovery from a milder form of injury more similar to human pancreatitis. To test this, we used transgenic mice expressing diphtheria toxin receptor (DTR) under the control of the myeloid-specific CD11b promoter (CD11b-DTR), allowing us to deplete CD11b þ myeloid cells by administering DT. 27 To induce injury, we repeated cerulein injections twice daily for 2 weeks, and harvested pancreata 1 and 7 days later ( Figure 1A) . 28 Two weeks of cerulein treatment resulted in a severe form of acute pancreatitis including tissue atrophy and ADM, accompanied by macrophage infiltration ( Figure 1B ). With 7 days of recovery, the number of macrophages decreased and repopulation of acinar cells was evident by an increase in amylase-positive cells and a decrease in Cytokeratin 19 (CK19)-positive ductal cells (Figure 1Ca-d) . Strikingly, depletion of myeloid cells throughout the 7-day recovery period prevented restoration of the acinar cell compartment (Figure 1Ce -h) but did not affect relative pancreatic mass ( Figure 1D ). All pancreata showed numerous Ki67 þ cells, with the majority being acinar cells in saline-treated controls ( Figure 1E and Fa, arrows), but limited to the interstitial space in DT-treated mice ( Figure 1E and Fb, arrowheads). The lack of acinar cell proliferation in DT-treated mice was accompanied by a significantly higher number of cleaved caspase-3 þ apoptotic cells compared with saline-treated controls ( Figure 1G and H) . Thus, consistent with other injury models, Abbreviations used in this paper: ADM, acinar-to-ductal metaplasia; BrdU, bromodeoxyuridine; Ct, threshold cycle; DMEM, Dulbecco's modified Eagle medium; DSB, DNA double-strand break; DTR, diphtheria toxin receptor; EGFR, epidermal growth factor receptor; FlpO, codon-optimized Flp recombinase; HB-EGF, heparin-binding epidermal growth factor-like growth factor; H4K20me1, histone H4 monomethylated at lysine residue 20; H4K20me2, histone H4 dimethylated at lysine residue 20; IHC, immunohistochemistry; IL, interleukin; MEK, mitogen-activated protein kinase kinase; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; ROS, reactive oxygen species; sHB-EGF, soluble heparin-binding epidermal growth factor-like growth factor; siRNA, small interfering RNA; TNFa, tumor necrosis factor a. 
HB-EGF Is Expressed in Macrophages During Pancreatitis
We and others have shown that EGFR/Mitogen-activated protein kinase kinase (MEK) signaling is critical for acinar cell proliferation and ADM. 9, 11, 29 In turn, macrophages are an abundant source of EGFR ligands in many disease states, including pancreatitis. 22, 30 Given the decreased acinar cell proliferation upon myeloid cell depletion after pancreatic injury, we asked whether macrophage EGFR ligands may be responsible. First, we determined the expression of EGFR ligands in macrophages isolated from pancreata with 2-week cerulein treatment followed by 1-or 7-day recovery. To collect a sufficient number of macrophages for RNA analysis, CD45 þ ;CD11b þ ;F4/80 þ cells were sorted from a pool of pancreata (4-5 pancreata/cohort). Among 9 EGFR ligands examined, HB-EGF was expressed predominantly in macrophages from 1-and 7-day recovered tissue (Figure 2A) . A panel of macrophage polarization marker genes suggested that the macrophages skewed toward alternatively activated macrophages in this model of experimental pancreatitis ( Figure 2B ), consistent with previous reports. 19 
Ablation of HB-EGF From Myeloid Cells Delays Pancreas Repair After Injury
To directly address whether HB-EGF derived from the myeloid cell compartment is involved in macrophagedependent recovery after pancreatic injury, we generated Hbegf f/f ;LysM-Cre 31,32 mice to ablate Hbegf specifically from myeloid cells. Eight-week-old LysM-Cre and Hbegf f/f ;LysM-Cre, mice were treated with cerulein twice daily for 2 weeks followed by 1-, 3-, 5-, or 7-day recovery ( Figure 3A ). Both cohorts of mice showed comparable initial damage at day 1 of recovery, with a similar relative pancreatic mass and histology, marked by acinar cell dropout, ADM, inflammatory cell infiltration, and abundant collagen deposition ( Figure 3B , C, and E). However, unlike LysM-Cre control mice, whose relative pancreatic mass stabilized by 7 days after the last cerulein treatment, Hbegf f/f ;LysM-Cre mice showed progressive pancreatic atrophy ( Figure 3B and C). LysM-Cre pancreata showed few signs of injury after a 7-day recovery, marked by restoration of acinar tissue and resolution of the collagen-rich stroma. In contrast, Hbegf f/f ;LysM-Cre pancreata had persistent ADM and unresolved fibrosis ( Figure 3D ).
Abundant macrophage infiltration was found in both LysM-Cre and Hbegf f/f ;LysM-Cre pancreata at 1-day recovery, Figure 3G ). These results suggest that myeloid cell-derived HB-EGF does not affect the overall inflammatory response and is more likely acting directly within the local environment to restore pancreatic acinar cells after injury.
As in our earlier experiments, LysM-Cre pancreata had a substantial number of Ki67-positive parenchymal cells at both 1 and 7 days of recovery. In comparison, Hbegf f/f ; LysM-Cre pancreata had approximately 3-fold fewer Ki67-positive cells ( Figure 4A ). The cyclin-dependent kinase inhibitor p21, which promotes cell-cycle arrest in G1, was detected in twice as many epithelial cells in Hbegf f/f ;LysMCre pancreata compared with LysM-Cre control tissue ( Figure 4B ). Cell proliferation at 1 day of recovery also was assessed by bromodeoxyuridine (BrdU) incorporation. Similar to the Ki67 results, the number of BrdU þ cells in the LysM-Cre pancreata was significantly higher than that in Hbegf f/f ;LysM-Cre pancreata ( Figure 4C ). IHC for cleaved caspase-3 showed 2-fold more apoptotic cells in Hbegf f/f ;LysM-Cre pancreata compared with LysM-Cre controls at up to 5 days of recovery ( Figure 4D) ; moreover, apoptotic cell death occurred primarily within the epithelium (E-cadherin positive) ( Figure 4E ) and not fibroblasts (a-smooth muscle actin positive) ( Figure 4F ). Collectively, these data suggest that the combination of decreased cell proliferation and increased apoptosis is responsible for continuing pancreatic atrophy in mice lacking myeloid cell-derived HB-EGF.
Myeloid-Derived HB-EGF Is Required for Resolution of DNA Damage During Recovery From Pancreatitis
DNA damage is common in inflammatory diseases, largely owing to an excess of reactive oxygen species (ROS) and reactive nitrogen species produced by inflammatory and epithelial cells. [33] [34] [35] On the other hand, macrophages facilitate DNA repair in a model of liver injury. 36 To test whether macrophages play a similar role in pancreatitis, we examined the formation of gH2AX nuclear foci. Histone H2AX phosphorylated at Ser139, referred to as gH2AX, flanks DNA double-strand breaks (DSBs) in response to DNA damage. 37 By IHC, gH2AX was significantly higher in the pancreata of DT-treated CD11b-DTR mice, compared with saline-treated controls ( Figure 5A ). Similarly, we observed very strong gH2AX foci in Hbegf f/f ;LysM-Cre pancreata as early as day 1 of recovery compared with LysM-Cre controls, although the number of cells expressing gH2AX was similar. By 7 days of recovery, gH2AX positivity decreased sharply in LysMCre pancreata, but persisted in Hbegf f/f ;LysM-Cre pancreata ( Figure 5B ). Because discrete gH2AX nuclear foci are a useful tool to highlight DSBs, we quantitated gH2AX nuclear punctate dots by immunofluorescence ( Figure 5C , arrowheads). We found that Hbegf f/f ;LysM-Cre pancreata had more DSBs than LysM-Cre pancreata ( Figure 5D ), and DNA damage occurred mainly in pancreatic epithelial cells ( Figure 5E ). We also noted that the staining pattern for gH2AX was not confined to nuclear punctate dots but also was observed as an annular staining of the outer portion of the nucleus (known as an apoptotic ring) and a panstaining of the nucleus ( Figure 5C and F, arrows). 38 These nonpunctate staining patterns are an indicator of DNA damage-induced apoptotic cell death. 38 Indeed, cleaved caspase-3 co-stained cells with gH2AX apoptotic Figure 2 . Experimental pancreatitis is abundantly infiltrated with alternatively activated macrophages expressing EGFR ligands. Total RNA of macrophages (CD45 þ ;CD11b þ ;F4/80 þ ) was isolated from a pool of pancreata (4-5 pancreata/cohort) treated with cerulein after recovery for 1 or 7 days and analyzed by reverse-transcription quantitative PCR for (A) EGFR ligands and (B) macrophage markers. Alternatively activated macrophage markers are found in inflammatory zone protein (Fizz1) and arginase I (ArgI). Classically activated macrophage markers are Il12b, Tnfa, and nitric oxide synthase 2 (Nos2). Areg, amphiregulin; Egf, epidermal growth factor; Ereg, epiregulin; Tgf-a, transforming growth factor a; Nrg, neuregulin.
rings and pan-nuclear staining ( Figure 5F , arrows), but not cells with gH2AX nuclear punctate dots ( Figure 5F , arrowheads). Consistent with the overall increase in cell death in mutant mice, we found a greater number of gH2AX apoptotic patterns in pancreata from Hbegf f/f ; LysM-Cre, compared with control ( Figure 5G ). These data suggested that ablation of myeloid cell HB-EGF impairs the DNA repair response, leading ultimately to cell death. 
were analyzed further for different subtypes by labeling with TNF-a and CD206 antibodies (n ! 3). Significance was calculated by 2-way analysis of variance with Tukey multiple comparison. *P < .05, **P < .01, ***P < .001, and ****P < .0001.
Soluble HB-EGF Promotes Resolution of DNA Damage in Pancreatic Cells In Vitro
The unresolved accumulation of gH2AX in Hbegf f/f ;LysMCre pancreata long after cessation of cerulein treatment led us to investigate the role of HB-EGF in DNA repair in pancreatic acinar cells. To dissect this mechanism, we used the mouse pancreatic acinar cell line 266.6 to study the role of soluble HB-EGF (sHB-EGF) in DNA repair in response to H 2 O 2 -induced DNA damage. The cells were treated with H 2 O 2 for 1 hour to induce DNA damage followed by HB-EGF incubation for the indicated times. We found that gH2AX accumulation was induced within 1 hour of H 2 O 2 treatment and continued to accumulate for 2 hours after washing away H 2 O 2 ; in comparison, addition of sHB-EGF caused a rapid decrease in gH2AX within 1 hour after treatment ( Figure 6A ).
Histone H4 methylated at lysine residue 20 (H4K20) plays diverse roles in cellular processes based on the degree of methylation. Monomethylation of H4K20 (H4K20me1) is associated mainly with cell-cycle progression, whereas H4K20me2 becomes a mediator for DNA damage checkpoint activation. 39 Monomethylation and dimethylation of H4K20 is regulated by nuclear EGFR in response to EGF and ionic radiation. 40 Similar to EGF, HB-EGF is capable of inducing EGFR translocation to the nucleus. 41 To test if this mechanism is in play in pancreatitis, we found that addition of sHB-EGF after inducing DNA damage efficiently increased the level of H4K20me1 within 1 hour. Subsequently, the level of H4K20me2 was increased within 2 hours as it was converted from H4K20me1 ( Figure 6A ). To directly measure DNA breaks, we performed a "comet assay." In this assay, DNA breaks are visualized using electrophoresis, with damaged DNA (the tail) trailing the intact DNA (the head) resembling a comet. 42 One-hour H 2 O 2 treatment strongly induced DNA strand breaks in the 266.6 cells, as determined by measuring the length of the comet tail. Because sHB-EGF was supplemented after H 2 O 2 removal, DNA in the comet tails was rapidly shifted to the comet heads within 3 hours, indicating that sHB-EGF promoted DNA repair ( Figure 6B ).
To test for EGFR nuclear translocation, 266.6 cells were treated with H 2 O 2 followed by sHB-EGF. Cytoplasmic and nuclear fractions were collected and immunoblotted for EGFR. Nuclear EGFR levels were increased significantly within 15 minutes of sHB-EGF treatment after H 2 O 2 stimulation, decreasing to a level similar to that in cells treated with HB-EGF alone within 45 minutes. EGFR remained in the cytoplasmic fraction in cells not treated with sHB-EGF after H 2 O 2 removal ( Figure 6C ). Total EGFR levels were decreased in cells treated with sHB-EGF after 30 minutes of stimulation ( Figure 6C ), consistent with proteasome-mediated 43 To further show that sHB-EGF-stimulated DNA repair is EGFR dependent, small interfering RNA (siRNA)-mediated knockdown of EGFR was performed. Knockdown of EGFR in 266.6 cells resulted in a concomitant decrease in dimethylated H4K20 formation and persistent accumulation of gH2AX, both indicative of inefficient DNA repair ( Figure 6D ). These findings suggest that upon DNA damage, sHB-EGF enhances EGFR nuclear translocation, which, in turn, regulates H4K20 methylation and subsequent DNA repair.
Myeloid Cell-Derived HB-EGF Regulates DNA Repair In Vivo
To test if our in vitro findings accurately reflect the in vivo condition, we first stained experimental pancreatitis tissue for EGFR to examine nuclear translocation. Unfortunately, under these conditions, nuclear EGFR was beneath the level of detection by IHC or immunofluorescence. We turned instead to the downstream consequences of EGFR translocation, such as H4K20 methylation, to test for myeloid cell HB-EGF-dependent regulation. IHC for H4K20me2 in day 1 recovered pancreata showed that LysM-Cre pancreata had more H4K20me2 þ epithelial cells than Hbegf f/f ;LysM-Cre pancreata ( Figure 7A, arrows) . Co-immunofluorescence staining for H4K20me2, E-cadherin, and a-smooth muscle actin showed that H4k20me2 formed nuclear punctate dots mainly in epithelial cells (E-cadherin þ ) ( Figure 7B , arrows). Because H4K20me2 is responsible for recruitment of the DNA repair factor p53-binding protein 1 to sites of DNA damage, 44 we quantitated cells containing p53-binding protein 1 nuclear foci after 1 day of recovery. Consistent with our H4K20me2 results, Hbegf f/f ;LysM-Cre pancreata had fewer 53BP1 þ cells ( Figure 7C ). Together, these results indicated that myeloid cell-derived HB-EGF regulates the cascade of H4K20 methylation and 53BP1 recruitment to damaged chromatin, promoting efficient DNA repair after pancreatic damage.
EGFR Is Required for Efficient DNA Repair During Recovery From Pancreatitis
Our inability to detect nuclear EGFR in vivo prompted us to test if EGFR is, in fact, critical for resolving DNA damage after pancreatic wounding as our data would suggest. Unfortunately, pancreas-specific ablation of EGFR before cerulein treatment completely protects the pancreas from cerulein-induced ADM and formation of the fibroinflammatory stroma. 9 The lack of inflammatory microenvironment resulting in no obvious DNA damage makes this model inappropriate for testing the role of EGFR specifically during the recovery phase. Likewise, efficient ablation 
, and E-cadherin (E-cad) (red) or (F) a-smooth muscle actin (a-SMA) (red) on 1-day recovery pancreata of LysMCre and Hbegf f/f ;LysM-Cre mice. Scale bar: 20 mm. *P < .05; **P < .01; ***P < .001; and ****P < .0001.
specifically after wounding using tamoxifen-induible Cre recombinase (Cre ERT ) models was impossible because in existing Cre ERT models, expression is dependent on the differentiation status of target cells (ie, acinar vs metaplastic duct cells). To overcome these limitations, we developed the Egfr f/f ;Ptf1a FlpO/þ ;FSF-Rosa26 CAG-CreERT2 mouse. The novel Ptf1a
FlpO/þ allele has a codon-optimized Flp recombinase (FlpO) knocked into the Ptf1a locus, driving FlpO expression and flippase recognition target (Frt)-based recombination ( Figure 8A) . Surprisingly, unlike the Ptf1a
Cre driver line, which efficiently directs loxP-mediated recombination in pancreas progenitor cells, resulting in recombination in most adult parenchymal cells, 45 lineage tracing showed that Ptf1a
FlpO -driven FRT-mediated recombination largely bypassed islet and duct cell recombination, suggesting inefficient recombination in the pancreatic progenitors, with efficient recombination primarily limited to adult acinar cells ( Figure 8B ). By crossing Ptf1a
FlpO mice to mice carrying a tamoxifen-inducible Cre ERT transgene under the control of a universal CMV enhancer, chicken beta-actin promoter (CAG), interrupted by an Frt-flanked transcriptional/translational stop (STOP) cassette (FSF) and knocked into the ROSA26 locus (FSF-Rosa26 CAG-CreERT2 ), 46 we created a model that allows us to induce Cre-lox recombination in acinarderived cells independent of their plastic differentiation status in pancreatitis ( Figure 9A ).
To study tissue recovery after experimental pancreatitis, Egfr f/f ;Ptf1a
FlpO/þ ;FSF-Rosa26 CAG-CreERT2 mice were treated for 2 weeks with cerulein followed by 7 days of recovery. To knockout EGFR in pancreatic epithelial cells specifically during the recovery phase, tamoxifen was administered on day 13 of cerulein treatment for 3 consecutive days ( Figure 9A ). Control mice from an identical genotype were treated with vehicle in place of tamoxifen. Because the majority of acinar cells in the vehicle-treated mice were redifferentiated from metaplastic ducts after 7 days of recovery, the EGFR level was Figure 4 . Continued rarely detectable. Thus, pancreata were harvested at 24 hours after tamoxifen/vehicle for detecting EGFR expression. Pancreata from tamoxifen-treated mice showed widespread loss of EGFR on epithelial membranes compared with vehicle control ( Figure 9B ). Upon initial observation at 7 days of recovery, there were no apparent differences between cohorts, reflecting the complex role of EGFR in maintaining ADM. 9 Relative pancreas mass and cell proliferation of the EGFR knockout and control pancreata were not different and histologic examination of the pancreata showed a similar level of acinar cell recovery by 7 days after cerulein treatment ( Figure 9C ). These results are consistent with our previous finding that MEK activation is required to sustain ADM. 11 However, similar to the Hbegf f/f ;LysM-Cre phenotype, we found that the number of cells with gH2AX accumulation persisted in EGFR knockout pancreata ( Figure 9C ), indicating that ablation of EGFR in pancreatic epithelial cells indeed impair DNA repair. Moreover, unrepaired DNA ultimately resulted in cell death, showed by a concomitant increase in cleaved caspase 3 in EGFR ablated pancreata ( Figure 9C ). These results support an essential function for a paracrine HB-EGF/EGFR loop in DNA repair after pancreatic wounding.
Discussion
In response to tissue injury, pancreatic acinar cells transdifferentiate to proliferative metaplastic ducts that are capable of partially regenerating acinar cell mass. 10, 47, 48 Our previous studies showed that the EGFR-MEK signaling axis is required for acinar cell proliferation and ADM, in part through acinar cell autonomous signaling. 9, 11 However, the role of macrophages in these early processes has been implicated, 18 ,49 suggesting a critical role for paracrine signaling. Macrophages express abundant EGFR ligands, with HB-EGF expression a prominent feature of macrophages that infiltrate the wound site. 22 Here, we found that myeloid-derived HB-EGF has no effect on initiation of EGFR-dependent ADM formation during cerulein-induced pancreatitis, consistent with this process being initiated by parenchymally derived ligands. 9 On the other hand, myeloid-derived HB-EGF plays a unique and profound role in promoting epithelial DNA repair, a function for which other EGFR ligands emanating from the damaged epithelium or stroma are clearly insufficient.
The delayed recovery from experimental pancreatitis when either myeloid cells were depleted or myeloid HB-EGF was ablated was evident from the failure to restore the acinar cell population. However, pancreatic tissue atrophy was observed only in the Hbegf f/f ;LysM-Cre mice, a difference possibly attributable to the absence of myeloid HB-EGF throughout the entirety of pancreatitis initiation and tissue recovery, whereas myeloid cell depletion was initiated beginning 1 day after cerulein treatment. (G) Quantitation of gH2AX apoptotic patterns includes cells containing gH2AX-ring staining, nuclear pan staining, and staining on apoptotic bodies (n ¼ 3). Significance was calculated using 2-way analysis of variance with Tukey multiple comparison. *P < .05, **P < .01, and ****P < .0001.
Epithelial cell proliferation was significantly lower in mice lacking myeloid HB-EGF, as determined by Ki67 expression and BrdU incorporation. Together with high levels of p21 expression, this indicates that without myeloid HB-EGF, pancreatic epithelial cells arrest in the G1 phase of the cell cycle, consistent with a defective DNA damage response. 50 Cell-cycle arrest induced by DNA damage checkpoints allow time for repair before initiating DNA synthesis. Unrepaired DNA lesions ultimately enforce permanent growth arrest or cell death. 50 We found that gH2AX þ DSBs persisted in mice lacking myeloid HB-EGF through 7 days of recovery. This persistent DNA damage was associated with an increased level of DNA damageassociated cell death, identified by both gH2AX þ apoptotic patterns and cleaved caspase-3. This enhanced level of apoptotic cell death, together with the muted proliferative response, likely contributes to the dramatic progressive pancreatic atrophy long after the cessation of tissue damage. In response to DNA damage, gH2AX serves as a platform on DNA breaks for the initial recruitment and retention of DNA repair factors, such as 53BP1. In mice lacking myeloid HB-EGF, we find less focal enrichment of 53BP1 in pancreatic epithelia even as gH2AX continues to accumulate. Recruitment of 53BP1 to damaged chromatin is associated with various histone modifications, including histone H4 methylation at lysine 20. 44 H4K20me2 has been linked to DNA damage response because it physically interacts with and stabilizes 53BP1. 51, 52 Consistent with the defect in 53BP1 recruitment, we found a decrease in H4K20me2 in pancreatic epithelia in Hbegf f/f ;LysM-Cre pancreata. In vitro, addition of ectopic HB-EGF increases the level of H4K20me2, which correlates to a decrease in gH2AX levels.
Nuclear EGFR has been suggested to be a regulator of H4K20 methylation in response to ionizing radiation and EGF. 40 We found that HB-EGF is capable of inducing EGFR nuclear translocation, an effect that is further enhanced when cells have DNA damage. Nuclear EGFR was difficult to detect in vivo, presumably because it turns over rapidly in response to HB-EGF, consistent with our in vitro experiments. We previously showed that ablating parenchymal þ cells were excluded from quantitation. Significance was calculated using an unpaired t test. *P < .05. Figure 6 . (See previous page). Soluble HB-EGF promotes DNA repair through EGFR in vitro. (A and C) The 266.6 cells were exposed to 500 mmol/L H 2 O 2 for 1 hour followed by treatment with/without sHB-EGF for the indicated times. (A) Wholecell lysates were analyzed by immunoblotting for gH2AX, H4K20me1, H4K20me2, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (a loading control). (C) Cytosolic and nuclear fractions were isolated from 266.6 cell lysates. EGFR was analyzed by immunoblotting. Lamin A/C and b-tubulin were used as loading and purity controls for nuclear and cytosolic fractions, respectively. (B) Representative images of comet assay from 266.6 cells treated with nothing (no Tx) or H 2 O 2 in serum-free DMEM for 1 hour followed by 3-hour recovery in DMEM (H 2 O 2 þ3hR) or sHB-EGF supplement (H 2 O 2 þ3h sHB-EGF). Quantitation of DNA in the comet tail was performed by analyzing 150 cells for each sample from 3 separate independent experiments. Scale bar: 200 mm. (D) EGFR knockdown was performed in 266.6 cells transfected with siRNA control (siRNA-C) or siRNA against EGFR (siRNA-egfr). At 48 hours after transfection, cells were treated with H 2 O 2 for 1 hour followed by HB-EGF treatment for the indicated time. Cell lysates were analyzed by immunoblotting for EGFR, gH2AX, H4K20me2, and GAPDH. Significance was calculated by 1-way analysis of variance with (A, C, D) Fisher's LSD and (B) with Tukey multiple comparison test. *P < .05, **P < .01, ***P < .001, and ****P < .0001.
EGFR before cerulein treatment protects the pancreas from cerulein-induced ADM and formation of the fibroinflammatory stroma, 9 initially preventing us from testing if EGFR does play a role in vivo during recovery from injury. To bypass this limitation, we created a novel conditional EGFR knockout mouse (Egfr f/f ;Ptf1a FlpO/þ ;Rosa CreER/þ ) that allows us to leave EGFR intact during the damage phase of experimental pancreatitis but to ablate it specifically in pancreatic epithelia cells only during recovery. Surprisingly, we did not detect tissue atrophy or a delay of acinar cell recovery with EGFR ablation, possibly owing to EGFR's role in maintaining ADM, a function suggested by our previous studies.
9,11 Nonetheless, we did find significant accumulated DNA damage in the pancreata with a lack of EGFR, consistent with the specific role of HB-EGF in this aspect of tissue healing.
DNA damage is the most significant consequence of oxidative stress. 53 Tobacco smoke and alcohol consumption, the most common stimuli of pancreatitis in people, can dramatically increase ROS, resulting in oxidative stress. 34, 35 Subsequently, abundant inflammatory cell infiltration into the injured pancreas leads to a microenvironment rich in ROS. In parallel, cerulein, used here to induce tissue damage, stimulates nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) activity in acinar cells to produce ROS, leading to the recruitment of inflammatory cells. 54 Inflammation has the potential to increase ROS further, increasing DNA damage, which can lead to cell death if not resolved. 33 Consistent with their contribution to tissue damage, others have shown that macrophage ablation before the induction of experimental pancreatitis is protective. 18 Here, we find that macrophage ablation specifically during the healing phase of experimental pancreatitis stymies tissue repair and prevents the resolution of DNA damage. Macrophage-enhanced DNA repair was seen previously in the livers of mice treated with diethylnitrosamine. This response reportedly was blocked by systemic administration of CRM197, 36 an HB-EGF inhibitor that specifically recognizes the human form of HB-EGF, but does not recognize the mouse protein. 55 To avoid this controversy, we generated conditional knockout mice targeting myeloid HB-EGF and parenchymal EGFR. With these unique and precise models we have definitively identified that macrophages promote pancreatic wound healing by producing HB-EGF to stimulate epithelial EGFR-mediated DNA repair, suggesting that HB-EGF could be used in therapy for pancreatitis. However, if the inflamed microenvironment also leads to oncogenic mutation in KRAS in the epithelium, stimulation of EGFR/MEK signaling also will promote tumorigenesis. 9, 29, 56 Our results emphasize that targeting the complex activities of pancreas disease-associated macrophages demands cautious scrutiny.
Methods
Mice
All animal experiments and procedures were conducted with the approval of the Institutional Committee on Use and Care of Animals at the University of Michigan. 
;Ptf1a
FlpO/þ and FSF-R26
CAG-CreERT2/þ animals (a gift from Dieter Saur, Technical University of Munich, Munich, Germany). 46 Mice bearing the Ptf1a FlpO allele were derived by recombinase-mediated cassette exchange using previously described methods and mouse embryonic stem cells (mESCs) containing a floxed cassette acceptor allele with the Ptf1a gene locus (15286998, 18294628). 45, 57 Briefly, a Ptf1a FlpO(HygroR) cassette exchange vector was constructed that replaces Ptf1a coding sequences with a FlpO coding sequence. FlpO was amplified from pPGKFLPobpA (made by Phil Soriano, obtained from Addgene Watertown, MA). 58 After using the Ptf1a FlpO(HygroR) exchange to perform recombinase-mediated cassette exchange, cells were screened by polymerase chain reaction (PCR) to identify correctly exchanged clones, and cells from a single selected clone (2F12/2B4) were injected into C57BL/6J blastocysts to generate chimeric mice, which then bred with other C57BL/6J mice to produce Ptf1a FlpO mice. Ptf1a FlpO mice are genotyped by PCR using the primer pair FLPO327-2F (5'-GGA GTTCACCATCATCCCTTACAACG-3') and FLPO755-R (5'-CTCAGGAACTCGTCCAGGTACA-3').
Experimental pancreatitis was induced, as described previously, by administering 250 mg/kg cerulein (46-1-50; American Peptide Company, Inc, Sunnyvale, CA) intraperitoneally twice daily for 2 weeks in 8-week-old mice 11 For myeloid cell depletion, 25 mg/kg DT (BML-G135-0001; Enzo Life Science, New York, NY) was injected intraperitoneally at day 1 and day 4 after cerulein treatment. 59 For EGFR ablation, mice were gavaged once daily with corn oil (vehicle) or 5 mg tamoxifen (T5648; Sigma-Aldrich, St. Louis, MO) for 3 days. For BrdU (bromodeoxyuridine) incorporation, BrdU (B9285; Sigma-Aldrich) was prepared in saline and 50 mg/kg was injected intraperitoneally 2 hours before euthanasia. CreERT/þ mice treated with 2 weeks of cerulein followed by vehicle or tamoxifen treatment (n > 3). Scale bar: 50 mm. Significance was calculated using an unpaired t test. *P < .05, **P < .01.
Immunohistochemistry and Quantification
Pancreata were removed and fixed in Z-fix (NC9050753; Anatech, Ltd, Battle Creek, MI) overnight. Tissues were processed using a Leica ASP300S tissue processor (Buffalo Grove, IL). Paraffin-embedded tissues were sectioned at 4 mm and stained for specific target proteins using the Discovery Ultra XT autostainer (Ventana Medical Systems, Inc, Tucson, AZ) with antibodies as shown in Table 1 , and counterstained with Mayer's hematoxylin. H&E staining was performed using Mayer's hematoxylin solution (NC9220898; Sigma-Aldrich) and eosin Y (HT110116; Fisher, Pittsburgh, PA). Picrosirius red staining was performed according to the manufacturer's instructions (Polysciences, Inc, Warrington, PA). Immunohistochemistry slides were scanned on a Pannoramic SCAN scanner (Perkin Elmer, Seattle, WA). Scanned images were quantified using algorithms provided from Halo software (Indica Labs, Corrales, NM).
Immunofluorescence and Quantification
Immunofluorescence performed on frozen sections was described previously. 60 Basically, pancreata were excised and fixed in Z-fix for 3 hours, followed by an overnight float in 30% sucrose. Pancreata were incubated in a 1:1 mixture of 30% sucrose and optimal cutting temperature embedding medium (OCT) for 30 minutes, embedded in OCT, frozen in liquid nitrogen, and stored at -80 C. Tissue sections (7 mm) were permeabilized in 1Â phosphate-buffered saline (PBS) supplemented with 0.1% Triton X-100 (T9284; SigmaAldrich, St. Louis, MO) for 1 hour and blocked in 1Â PBS supplemented with 5% donkey serum and 1% bovine serum albumin for 1 hour. Sections then were incubated with primary antibody diluted in 1Â PBS supplemented with 0.1% Triton X-100 and 1% bovine serum albumin overnight at room temperature, followed by 3 washes in 0.1% Triton X-100/PBS for a total of 1 hour. Sections were incubated with secondary antibodies conjugated with Alexa Fluor (Invitrogen, Carlsbad, CA) for 1 hour at room temperature, followed by 3 washes in 0.1% Triton X-100/PBS. Stained slides were rinsed in deionized water and mounted with Prolong Diamond antifade mountant (P36961; Fisher). Images were acquired on a confocal microscope LSM800 (Zeiss, Oberkochen, Germany).
Co-immunofluorescence with Tyramide Signal Amplification (TSA) was performed using the TSA-plus fluorescence evaluation kit (NEL741E001KT; Perkin Elmer) on paraffin-embedded sections for gH2AX and cleaved caspase-3. For quantification of nuclear foci of gH2AX and 53BP1, images were taken by a confocal microscope (LSM800; Zeiss). Four to 6 separated 60Â fields (>300 cells) were quantified for each pancreas sample using the find maxima function of ImageJ software (National Institutes of Health, Bethesda, MD). Cells containing gH2AX apoptotic patterns (ring staining, nuclear pan-staining, and pan-staining in apoptotic bodies) were quantified manually on 60Â images taken by confocal microscope. The total cell number was counted by HALO (Perkin Elmer, Seattle, WA) software based on Hoechst 33342 staining. CD45 þ cells were excluded.
Flow Cytometric Sorting
Preparation of single-cell suspensions of pancreas was performed as previously described. 49 Briefly, pancreata were minced using a pair of dissecting scissors, followed by digestion in 1 mg/mL collagenase type V (C9263; Sigma) in Hank's balanced salt solution (SH3026801; Fisher) for 15 minutes at 37 C. Cells were washed in Hank's balanced salt solution once, followed by incubation in RBS lysis buffer (420301; Biolegend, San Diego, CA) for 5 minutes. After passing through a 40-mm strainer (22363547; Fisher), single-cell suspensions were incubated with fluorescently conjugated antibodies (as shown in Table 1 
Cell Culture and Treatment
A total of 266.6 cells were purchased from American Type Culture Collection (Manassas, VA) and maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (F2442; Sigma-Aldrich) and 50 ug/mL gentamicin (15710072; Thermo Fisher Scientific, Waltham, MA) in a 37 C incubator with 5% CO 2 . H 2 O 2 (NDC0869087143; Thermo Fisher Scientific) was used at a final concentration of 500 mmol/L for 1 hour at 37 C. Mouse recombinant HB-EGF (CYT-068; ProSpec, East Brunswick, NJ) was used to treat cells at a final concentration of 100 ng/mL in serum-free DMEM. Transfection of siRNA was performed using the Lipofectamine RNAiMax reagent kit according to the manufacturer's protocol (13778075; Thermo Fisher Scientific). Nontargeting and mouse Egfr siRNAs were purchased from (Dharmacon, Lafayette, CO). After 48 hours of transfection, cells were treated with H 2 O 2 for DNA damage response experiments.
Immunoblot Analysis
Cells were lysed in RIPA buffer supplemented with protease inhibitor cocktail (PIA32965; Thermo Fisher Scientific) and PhosSTOP phosphatase inhibitor cocktail (4906845001; Sigma-Aldrich) followed by sonication. Protein concentrations were determined using the BCA Protein Assay Kit (PI23228; Thermo Fisher Scientific). A nuclear-cytoplasmic fraction was made using NE-PER nuclear and cytoplasmic extraction reagents kit (78833; Thermo Fisher Scientific) according to the manufacturer's protocol. Proteins were separated using sodium dodecyl sulfate gel electrophoresis and transferred to a polyvinylidene difluoride membrane (IPVH00010; VWR, Radnor, PA). Primary antibodies are listed in Table 1 . Secondary antibody coupled to horseradish peroxidase (GE Healthcare, Pittsburgh, PA) and the enhanced chemiluminescence detection system (Western Pico ECL, Thermo Fisher Scientific) were used to visualize proteins. Quantification of Western blots was performed using ImageJ software. 
Nrg1
Forward AACAGCAGGCACAGCAGCCC
Reverse AGGGGAGCTTGGCGTGTGGA
Nrg2
Forward GGAGATCCAGATGGCAGATTAC
Reverse GTGAGAAGGTGAACAGGAGTG
Nrg3
Forward TGCCGAAAACAGACTCCATC
Reverse CCCACGATGACAATTCCAAAG
Nrg4
Forward GGACAGAGACAGCCTTAAACAG
Reverse AAGAATCGGAGAACTGAGCAC
